UK consumers reduced their purchases of food and alcohol during the Christmas season, with industry experts attributing the trend to the growing popularity of weight loss injections. Grocery sales amounted to £19.6 billion in the four weeks leading up to December 27, showing a 2.5% increase compared to the previous year, as reported by market research firm NielsenIQ. However, sales in terms of volume declined by 0.2%.
Analysts in the retail sector suggest that the connection between reduced purchases and the rise in GLP-1 injections usage is significant. These injections, such as Mounjaro and Wegovy prescribed by the NHS for weight loss and Ozempic for diabetes, have been utilized by approximately 1.6 million adults in the UK over the past year.
The impact of these weight loss medications on consumer behavior is evident, with Jonathan De Mello, a retail analyst at JDM Retail, noting a noticeable decline in grocery volume among users of GLP-1 drugs. Categories like snacks and alcohol have been particularly affected by this trend. Clive Black, a consumer analyst at Shore Capital, highlighted the influence of GLP drugs on eating habits, pointing to the decrease in the volume of groceries sold over the Christmas period.
Retailers are responding to this shift in consumer behavior by introducing smaller meal options. Co-op has launched a range of “mini meals” catering to individuals with smaller appetites, while Marks & Spencer and Iceland have introduced nutrient-dense and expanded frozen meal offerings, respectively.
The impact of weight loss injections on business operations is also being felt by companies like Greggs. The company’s CEO acknowledged the influence of weight loss jabs on sales performance, emphasizing the demand for smaller portions and healthier options among consumers.
Executives from major retailers like Tesco and Sainsbury’s are closely monitoring consumer trends influenced by the rise in weight loss medication, indicating a need for adaptation to changing shopper habits.